Estimating the Prevalence of AATD Patients in the UK to Identify Underdiagnosis and Determine the Eligibility for Potential Augmentation Therapy

PURPOSE: Alpha 1 antitrypsin deficiency (AATD) is a genetic risk factor for chronic obstructive pulmonary disease (COPD). Whilst testing for the condition is relatively simple, there is a disconnect in published literature between genetic epidemiology and numbers of patients known to specialists. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Newnham, Michael, Quinn, Mark, Turner, Alice M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276585/
https://www.ncbi.nlm.nih.gov/pubmed/37332838
http://dx.doi.org/10.2147/COPD.S395663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276585/
https://www.ncbi.nlm.nih.gov/pubmed/37332838
http://dx.doi.org/10.2147/COPD.S395663

Ejemplares similares